These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16187646)

  • 1. The drug add-on component--have all provider types seen budget neutrality?
    Mentz K
    Nephrol News Issues; 2005 Sep; 19(10):42-4. PubMed ID: 16187646
    [No Abstract]   [Full Text] [Related]  

  • 2. Conditions for coverage fail to relieve administrative burden.
    Wish D
    Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
    [No Abstract]   [Full Text] [Related]  

  • 3. Futuristic plans for ESRD--a new bundled payment system.
    Michael M
    Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
    [No Abstract]   [Full Text] [Related]  

  • 4. The 2011 ESRD prospective payment system: welcome to the bundle.
    Weiner DE
    Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
    [No Abstract]   [Full Text] [Related]  

  • 5. The 2011 ESRD prospective payment system: an uncontrolled experiment.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
    [No Abstract]   [Full Text] [Related]  

  • 6. The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.
    Bhat P; Bhat JG
    Am J Kidney Dis; 2011 Apr; 57(4):556-8. PubMed ID: 21316132
    [No Abstract]   [Full Text] [Related]  

  • 7. The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
    Nissenson AR; Mayne TJ; Krishnan M
    Am J Kidney Dis; 2011 Apr; 57(4):550-2. PubMed ID: 21333425
    [No Abstract]   [Full Text] [Related]  

  • 8. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 10. The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization.
    Johnson DS; Meyer KB; Johnson HK
    Am J Kidney Dis; 2011 Apr; 57(4):553-5. PubMed ID: 21333427
    [No Abstract]   [Full Text] [Related]  

  • 11. Who should be paying for vitamin D analogues--Medicare or the patients?
    Grotegut J
    Nephrol Nurs J; 2006; 33(3):345-6. PubMed ID: 16912996
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of HCFA's revised billing instructions for kinetic modeling and recirculation tests.
    Rosenthal AF; Mahlke KF
    Nephrol News Issues; 1998 Feb; 12(2):12. PubMed ID: 9526364
    [No Abstract]   [Full Text] [Related]  

  • 13. Who should be paying for vitamin D analogues--Medicare or the patients?
    Hall G
    Nephrol Nurs J; 2006; 33(3):345-6, 351. PubMed ID: 16859205
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
    Cellini GL
    Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
    [No Abstract]   [Full Text] [Related]  

  • 15. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting to changes in Medicare cost report requirements.
    Rossi T
    Nephrol News Issues; 2005 Sep; 19(10):36-9. PubMed ID: 16187645
    [No Abstract]   [Full Text] [Related]  

  • 17. Case-mix adjusted composite rate--did Medicare get it right?
    Messana A
    Nephrol News Issues; 2005 Sep; 19(10):44. PubMed ID: 16187647
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost of clinical dialysis--a historical perspective.
    Attrill E; Johnson HK
    Semin Nephrol; 2000 Nov; 20(6):523-5. PubMed ID: 11111853
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicare ESRD prospective payment system: weighing the evidence.
    Himmelfarb J; Chertow GM
    J Am Soc Nephrol; 2005 May; 16(5):1164-5. PubMed ID: 15829705
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it time for Medicare to provide reimbursement for daily hemodialysis?
    Newmann JM
    Nephrol News Issues; 2001 Apr; 15(5):57-9. PubMed ID: 12108965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.